Close
Nordic 9Nordic 9

InFocus Capital Partners (investor - Venture Capital)

United States infocuscapitalpartners.com
See something wrong or missing? Let us know
Offices:New York

InFocus Capital Partners is an American VC company that provides seed and early round funding to life science companies, specifically within ophthalmology.

Average round investment:7.52M USD
Average number per year:1.0
Distribution: 2022 (1)2020 (1)
Portfolio companies: United Kingdom Re-Vana Therapeutics
Mostly invests in: United Kingdom United Kingdom (2) Health services (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to InFocus Capital Partners

Name Criteria
United Kingdom Parkinson's UK
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Visionary Venture Fund
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States ExSight Ventures
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Cathexis Ventures
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Alex Chesterman
72%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Italy HTH - Health Technology Holding.
72%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Switzerland infinitas capital group
72%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Italy Pi Campus
72%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Spain Ekarpen
70%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Peppermint Venture Partners
70%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top